AAAAAA
Results: 1-25/56
Authors:
Richman, DD
Citation: Dd. Richman, Limitations of current therapies for HIV-1 infection, INFEC DIS T, 27, 2002, pp. 189-201
Authors:
Richman, DD
Citation: Dd. Richman, Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor, ANTIVIR TH, 6(2), 2001, pp. 83-88
Authors:
Corbeil, A
Sheeter, D
Genini, D
Rought, S
Leoni, L
Du, PY
Ferguson, M
Masys, DR
Welsh, JB
Fink, JL
Sasik, R
Huang, D
Drenkow, J
Richman, DD
Gingeras, T
Citation: A. Corbeil et al., Temporal gene regulation during HIV-1 infection of human CD4(+) T cells, GENOME RES, 11(7), 2001, pp. 1198-1204
Authors:
Genini, D
Sheeter, D
Rought, S
Zaunders, JJ
Susin, SA
Kroemer, G
Richman, DD
Carson, DA
Corbeil, J
Leoni, LM
Citation: D. Genini et al., HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism, FASEB J, 15(1), 2001, pp. 5-6
Authors:
Stuyver, LJ
Locarnini, SA
Lok, A
Richman, DD
Carman, WF
Dienstag, JL
Schinazi, RF
Citation: Lj. Stuyver et al., Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region, HEPATOLOGY, 33(3), 2001, pp. 751-757
Authors:
Havlir, DV
Gilbert, PB
Bennett, K
Collier, AC
Hirsch, MS
Tebas, P
Adams, EM
Wheat, LJ
Goodwin, D
Schnittman, S
Holohan, MK
Richman, DD
Citation: Dv. Havlir et al., Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression, AIDS, 15(11), 2001, pp. 1379-1388
Authors:
Havlir, DV
Bassett, R
Levitan, D
Gilbert, P
Tebas, P
Collier, AC
Hirsch, MS
Ignacio, C
Condra, J
Gunthard, HF
Richman, DD
Wong, JK
Citation: Dv. Havlir et al., Prevalence and predictive value of intermittent viremia with combination HIV therapy, J AM MED A, 286(2), 2001, pp. 171-179
Authors:
Hammond, JL
Koontz, DL
Bazmi, HZ
Beadle, JR
Hostetler, SE
Kini, GD
Aldern, KA
Richman, DD
Hostetler, KY
Mellors, JW
Citation: Jl. Hammond et al., Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance, ANTIM AG CH, 45(6), 2001, pp. 1621-1628
Authors:
Frost, SDW
Gunthard, HF
Wong, JK
Havlir, D
Richman, DD
Brown, AJL
Citation: Sdw. Frost et al., Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy, VIROLOGY, 284(2), 2001, pp. 250-258
Authors:
Hale, P
Makgoba, MW
Merson, MH
Quinn, TC
Richman, DD
Vella, S
Wabwire-Mangen, F
Wain-Hobson, S
Weiss, RA
Citation: P. Hale et al., Success hinges on support for treatment, NATURE, 412(6844), 2001, pp. 272-272
Authors:
Richman, DD
Citation: Dd. Richman, HIV chemotherapy, NATURE, 410(6831), 2001, pp. 995-1001
Authors:
Buhler, B
Lin, YC
Morris, G
Olson, AJ
Wong, CH
Richman, DD
Elder, JH
Torbett, BE
Citation: B. Buhler et al., Viral evolution in response to the broad-based retroviral protease inhibitor TL-3, J VIROLOGY, 75(19), 2001, pp. 9502-9508
Authors:
Gunthard, HF
Havlir, DV
Fiscus, S
Zhang, ZQ
Eron, J
Mellors, J
Gulick, R
Frost, SDW
Brown, AJL
Schleif, W
Valentine, F
Jonas, L
Meibohm, A
Ignacio, CC
Isaacs, R
Gamagami, R
Emini, E
Haase, A
Richman, DD
Wong, JK
Citation: Hf. Gunthard et al., Residual human immunodeficiency virus (HIV) type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years, J INFEC DIS, 183(9), 2001, pp. 1318-1327
Authors:
Horner, AA
Datta, SK
Takabayashi, K
Belyakov, IM
Hayashi, T
Cinman, N
Nguyen, MD
Van Uden, JH
Berzofsky, JA
Richman, DD
Raz, E
Citation: Aa. Horner et al., Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites, J IMMUNOL, 167(3), 2001, pp. 1584-1591
Authors:
Douek, DC
Betts, MR
Hill, BJ
Little, SJ
Lempicki, R
Metcalf, JA
Casazza, J
Yoder, C
Adelsberger, JW
Stevens, RA
Baseler, MW
Keiser, P
Richman, DD
Davey, RT
Koup, RA
Citation: Dc. Douek et al., Evidence for increased T cell turnover and decreased thymic output in HIV infection, J IMMUNOL, 167(11), 2001, pp. 6663-6668
Authors:
Daar, ES
Little, S
Pitt, J
Santangelo, J
Ho, P
Harawa, N
Kerndt, P
Giorgi, JV
Bai, JX
Gaut, P
Richman, DD
Mandel, S
Nichols, S
Citation: Es. Daar et al., Diagnosis of primary HIV-1 infection, ANN INT MED, 134(1), 2001, pp. 25-29
Authors:
Gifford, AL
Bormann, JE
Shively, MJ
Wright, BC
Richman, DD
Bozzette, SA
Citation: Al. Gifford et al., Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens, J ACQ IMM D, 23(5), 2000, pp. 386-395
Authors:
Lange, JMA
Richman, DD
Citation: Jma. Lange et Dd. Richman, Antiviral therapy in 2000, ANTIVIR TH, 5(1), 2000, pp. 1-1
Authors:
Richman, DD
Citation: Dd. Richman, Principles of HIV resistance testing and overview of assay performance characteristics, ANTIVIR TH, 5(1), 2000, pp. 27-31
Authors:
Pillay, D
Taylor, S
Richman, DD
Citation: D. Pillay et al., Incidence and impact of resistance against approved antiretroviral drugs, REV MED VIR, 10(4), 2000, pp. 231-253
Authors:
Hostetler, KY
Hammond, JL
Kini, GD
Hostetler, SE
Beadle, JR
Aldern, KA
Chou, TC
Richman, DD
Mellors, JW
Citation: Ky. Hostetler et al., In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine, ANTIVIR CHE, 11(3), 2000, pp. 213-219
Authors:
Gilbert, PB
Hanna, GJ
De Gruttola, V
Martinez-Picado, J
Kuritzkes, DR
Johnson, VA
Richman, DD
D'Aquila, RT
Citation: Pb. Gilbert et al., Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens, AIDS RES H, 16(14), 2000, pp. 1325-1336
Authors:
Richman, DD
Citation: Dd. Richman, The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B, HEPATOLOGY, 32(4), 2000, pp. 866-867
Authors:
O'Brien, TR
McDermott, DH
Ioannidis, JPA
Carrington, M
Murphy, PM
Havlir, DV
Richman, DD
Citation: Tr. O'Brien et al., Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy, AIDS, 14(7), 2000, pp. 821-826
Authors:
Zhou, XJ
Havlir, DV
Richman, DD
Acosta, EP
Hirsch, M
Collier, AC
Tebas, P
Sommadossi, JP
Citation: Xj. Zhou et al., Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients, AIDS, 14(18), 2000, pp. 2869-2876